Cost-Effectiveness of Exenatide Once Weekly Versus Insulin Glargine and Liraglutide for the Treatment of Type 2 Diabetes in Greece
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1871
https://www.valueinhealthjournal.com/article/S1098-3015(16)33237-5/fulltext
Title :
Cost-Effectiveness of Exenatide Once Weekly Versus Insulin Glargine and Liraglutide for the Treatment of Type 2 Diabetes in Greece
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33237-5&doi=10.1016/j.jval.2016.09.1871
First page :
A672
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1768